Archives
-
MPC, Lactate, and Histone Lactylation in Tumor Immunity
2026-09-21
A 2025 study identifies mitochondrial pyruvate carrier downregulation as a driver of lactate accumulation, histone lactylation, dendritic-cell dysfunction, and impaired CD8+ T-cell activity in colorectal cancer. Its gain- and loss-of-function design connects tumor metabolism with immune regulation and suggests that restoring MPC activity may improve anti-PD-1 responses.
-
SMYD2, miR-125b, and Drug Resistance in RCC
2026-09-20
This study identifies SMYD2 as an epigenetic driver of clear cell renal cell carcinoma progression and multidrug resistance, linking SMYD2 activity to miR-125b, DKK3, and P-glycoprotein regulation. Its combination of patient-prognostic analysis, molecular perturbation, drug-response testing, and xenograft validation provides a useful framework for investigating treatment resistance in RCC.
-
Doxorubicin and Persister-Cell Ferroptosis
2026-09-19
Doxorubicin research can reveal more than acute DNA damage: it can help interrogate the reversible persister states that shape treatment resistance. This article connects Adriamycin-based perturbation design with lipidomic evidence for ferroptosis vulnerability while defining the limits of that inference.
-
Cabazitaxel (XRP6258) Workflow Guide
2026-09-18
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble taxane derivative for controlled studies of microtubule dynamics disruption and antiproliferative responses in taxane-resistant or P-glycoprotein-expressing cancer models. This guide covers solvent selection, preparation, exposure planning, and QC while defining why direct aqueous preparation and long-term storage of solutions should be avoided.
-
SIRT6-AMPK–NLRP3 Control of Atrial Fibrillation
2026-09-18
The reference study identifies SIRT6-AMPK signaling as a mechanistic link between oxidative stress, NLRP3 inflammasome activation, atrial fibrosis, and susceptibility to atrial fibrillation. Using human atrial evidence, bioinformatics, and targeted murine interventions, it shows that berberine protects against angiotensin II-induced atrial remodeling through this pathway, while also defining important limits for translation.
-
Sodium Salicylate NF-κB Inhibitor Workflows
2026-09-17
Sodium salicylate provides a soluble, tunable way to interrogate NF-κB-linked inflammation, oxidative stress, and stromal signaling. This workflow distinguishes a mechanistic cell-culture probe from the spatially programmed nanomedicine reported for pancreatic tumor models, helping researchers design cleaner comparisons and troubleshoot assay variability.
-
ACE2 Peptidase Activity and Angiotensin (1-7)
2026-09-17
Saulnier and colleagues dissected how ACE2 recognizes angiotensin peptides by testing sequence-length variants against a fluorogenic substrate. Their results identify Ang II and Ang III as the strongest natural competitors while showing that removal of the C-terminal phenylalanine changes substrate interaction in a way that helps explain Angiotensin (1-7) formation.
-
Viral RIPK3 Degradation Controls Inflammation
2026-09-16
Liu et al. identified a cowpox virus protein family that recruits SCF ubiquitin-ligase machinery to target RIPK3 for proteasomal degradation, thereby suppressing necroptosis. Viral gain- and loss-of-function experiments showed that this vIRD–RIPK3 interaction influences orthopoxvirus replication, inflammation, and mortality in vivo, providing a mechanistic link between pathogen evolution and inflammatory disease.
-
A23187, free acid: Calcium Ionophore Workflows
2026-09-16
A23187, free acid provides a controllable way to elevate intracellular Ca2+ and connect calcium signaling with phosphoinositide metabolism, ROS generation, and cell death. This guide pairs practical ionophore workflows with a response-analysis framework that separates growth inhibition from true killing.
-
Metastatic Evolution and CRC Therapeutic Heterogeneity
2026-09-15
Cho and colleagues used patient-derived xenografts and multi-omic profiling to show that colorectal cancer metastasis can reshape subclonal architecture, gene expression, and DNA methylation in clinically relevant ways. The study links these dynamic changes to in vivo therapeutic heterogeneity, supporting matched, evolution-aware designs for colon cancer research.
-
MPC-Lactate Signaling and Dendritic-Cell Lactylation
2026-09-15
The 2025 reference study identifies mitochondrial pyruvate carrier (MPC) loss as a driver of lactate accumulation, histone lactylation, dendritic-cell dysregulation, and impaired CD8+ T-cell activity in colorectal cancer. Its experiments connect tumor metabolism with immune regulation and show that increasing MPC activity can improve anti-PD-1 responses, while also defining important limits for translating this mechanism to other disease areas.
-
Selective ClpP Activation in Lung Squamous Cell Carcinoma
2026-09-14
The reference study identifies ZK53 as a selective activator of human mitochondrial ClpP and explains how mitochondrial proteostasis disruption suppresses lung squamous cell carcinoma. By linking ClpP-dependent respiratory failure to E2F-associated transcriptional changes, ATM-mediated DNA damage signaling, and cell-cycle arrest, the work provides a mechanistic framework for mitochondrial-targeted cancer research.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA)
2026-09-14
This scenario-driven guide explains how 12-O-tetradecanoyl phorbol-13-acetate (TPA), SKU N2060, can improve the design and interpretation of PKC, ERK/MAPK, viability, and cytotoxicity experiments. It links formulation, stock handling, time-resolved sampling, orthogonal readouts, and vendor-selection decisions to practical laboratory reliability.
-
Dual-Network Microgels for Intervertebral Disc Degeneration
2026-09-13
The reference study develops POCM@MCCP, an elastic dual-network hydrogel microsphere that combines sustained miR-155 delivery with EGCG- and strontium-based modulation of the inflammatory disc microenvironment. Its stimulus-responsive release design suppressed inflammation, reduced apoptosis-associated signaling, limited oxidative stress, and improved nucleus pulposus cell function in in vitro and in vivo models of intervertebral disc degeneration.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-09-12
Translate astrocyte atlas discoveries into spatially resolved protein and RNA validation with sensitive tyramide deposition. This workflow shows how to adapt the Fluorescein TSA Fluorescence System Kit for developmental brain tissue, cultured cells, and low-abundance targets while controlling background and saturation.